Share-based Payment Arrangement, Expense in USD of Icosavax, Inc. from Q2 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Icosavax, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q2 2020 to Q3 2023.
  • Icosavax, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $6.6M, a 21.5% increase year-over-year.
  • Icosavax, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $25.1M, a 30.5% increase year-over-year.
  • Icosavax, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $21.7M, a 25.3% decline from 2021.
  • Icosavax, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $29M, a 11196% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Icosavax, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $25.1M $6.6M +$1.17M +21.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $23.9M $6.31M +$759K +13.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $23.1M $6M +$1.45M +31.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $21.7M $6.16M +$2.48M +67.5% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-30
Q3 2022 $19.2M $5.43M -$18.2M -77% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $37.4M $5.55M +$4.14M +294% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $33.3M $4.55M +$4.27M +1549% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $29M $3.68M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $23.7M +$23.6M +33714% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1.41M +$1.35M +2135% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $276K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 $70K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $63K Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-13

Icosavax, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $21.7M -$7.34M -25.3% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
2021 $29M +$28.8M +11196% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $257K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.